>>>   Click for Diagenode’s approach to COVID-19

PADI4 peptide

default alt
Catalog Number
50 µg/50 µl

Synthetic peptide corresponding to the N-terminal region of human PADI4. 
This peptide was used as immunogen to raise the Diagenode crude serum directed against PADI4 (Cat. No. CS-075-100). The same peptide can be used to block this antibody in negative control experiments. 

For more information about PADI4: see overview in the Technical Data Sheet of the corresponding Diagenode antibody (Cat. No. CS-075-100).

  •  Documents
    Datasheet PADI4 sp075 DATASHEET
    Datasheet description
    Datasheet PADI4 CS-075-100 DATASHEET
    Datasheet description
  •  Publications

    How to properly cite this product in your work

    Diagenode strongly recommends using this: PADI4 peptide (Diagenode Cat# C16000075). Click here to copy to clipboard.

    Using our products in your publication? Let us know!

  •  Related products

       Site map   |   Contact us   |   Conditions of sales   |   Conditions of purchase   |   Privacy policy   |   Diagenode Diagnostics